Close
  Indian J Med Microbiol
 

Figure 1: Majority (35, 58.3%) of subjects reported moderate effects followed by 25 (41.6%) of the subjects reported to have severe effects and none reported to have mild 0 (0%) effects

Figure 1: Majority (35, 58.3%) of subjects reported moderate effects followed by 25 (41.6%) of the subjects reported to have severe effects and none reported to have mild 0 (0%) effects